Mouse DLL1 ELISA Kit is a single-wash 90-min Simplestep used to quantify Mouse DLL1 with a sensitivity of 24 pg/ml. The assay uses a simple mix-wash-read protocol with just one incubation and one wash step.
- Colorimetric Sandwich ELISA - 450 nm readout : works on any standard plate reader
- Design your own immunoassay: we also offer the conjugation-ready antibody pair
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application sELISA | Reactivity Reacts | Dilution info - | Notes - |
Select an associated product type
Transmembrane ligand protein of NOTCH1, NOTCH2 and NOTCH3 receptors that binds the extracellular domain (ECD) of Notch receptor in a cis and trans fashion manner (PubMed:10958687, PubMed:21985982). Following transinteraction, ligand cells produce mechanical force that depends of a clathrin-mediated endocytosis, requiring ligand ubiquitination, EPN1 interaction, and actin polymerisation; these events promote Notch receptor extracellular domain (NECD) transendocytosis and triggers Notch signaling through induction of cleavage, hyperphosphorylation, and nuclear accumulation of the intracellular domain of Notch receptors (NICD) (PubMed:10958687, PubMed:18676613). Is required for embryonic development and maintenance of adult stem cells in many different tissues and immune systeme; the DLL1-induced Notch signaling is mediated through an intercellular communication that regulates cell lineage, cell specification, cell patterning and morphogenesis through effects on differentiation and proliferation (PubMed:16495313, PubMed:17194759, PubMed:17960184, PubMed:18997111, PubMed:19144989, PubMed:19389377, PubMed:19562077, PubMed:20081190, PubMed:21238454, PubMed:21572390, PubMed:22096075, PubMed:22282195, PubMed:22529374, PubMed:22940113, PubMed:23688253, PubMed:23695674, PubMed:23699523, PubMed:23806616, PubMed:25220152, PubMed:26114479, PubMed:7671806). Plays a role in brain development at different level, namely by regulating neuronal differentiation of neural precursor cells via cell-cell interaction, most likely through the lateral inhibitory system in an endogenous level dependent-manner (PubMed:18997111, PubMed:7671806). During neocortex development, Dll1-Notch signaling transmission is mediated by dynamic interactions between intermediate neurogenic progenitors and radial glia; the cell-cell interactions are mediated via dynamic and transient elongation processes, likely to reactivate/maintain Notch activity in neighboring progenitors, and coordinate progenitor cell division and differentiation across radial and zonal boundaries (PubMed:23699523). During cerebellar development, regulates Bergmann glial monolayer formation and its morphological maturation through a Notch signaling pathway (PubMed:23688253). At the retina and spinal cord level, regulates neurogenesis by preventing the premature differentiation of neural progenitors and also by maintaining progenitors in spinal cord through Notch signaling pathway (PubMed:19389377, PubMed:26114479). Also controls neurogenesis of the neural tube in a progenitor domain-specific fashion along the dorsoventral axis (PubMed:20081190). Maintains quiescence of neural stem cells and plays a role as a fate determinant that segregates asymmetrically to one daughter cell during neural stem cells mitosis, resulting in neuronal differentiation in Dll1-inheriting cell (PubMed:23695674). Plays a role in immune systeme development, namely the development of all T-cells and marginal zone (MZ) B cells (PubMed:15146182, PubMed:19217325). Blocks the differentiation of progenitor cells into the B-cell lineage while promoting the emergence of a population of cells with the characteristics of a T-cell/NK-cell precursor (By similarity). Upon MMP14 cleavage, negatively regulates Notch signaling in haematopoietic progenitor cells to specifically maintain normal B-cell development in bone marrow (PubMed:21572390). Also plays a role during muscle development. During early development, inhibits myoblasts differentiation from the medial dermomyotomal lip and later regulates progenitor cell differentiation (PubMed:17194759). Directly modulates cell adhesion and basal lamina formation in satellite cells through Notch signaling. Maintains myogenic progenitors pool by suppressing differentiation through down-regulation of MYOD1 and is required for satellite cell homing and PAX7 expression (PubMed:22940113). During craniofacial and trunk myogenesis suppresses differentiation of cranial mesoderm-derived and somite-derived muscle via MYOD1 regulation but in cranial mesoderm-derived progenitors, is neither required for satellite cell homing nor for PAX7 expression (PubMed:25220152). Also plays a role during pancreatic cell development. During type B pancreatic cell development, may be involved in the initiation of proximodistal patterning in the early pancreatic epithelium (PubMed:22529374). Stimulates multipotent pancreatic progenitor cells proliferation and pancreatic growth by maintaining HES1 expression and PTF1A protein levels (PubMed:22096075). During fetal stages of development, is required to maintain arterial identity and the responsiveness of arterial endothelial cells for VEGFA through regulation of KDR activation and NRP1 expression (PubMed:19144989). Controls sprouting angiogenesis and subsequent vertical branch formation through regulation on tip cell differentiation (PubMed:22282195). Negatively regulates goblet cell differentiation in intestine and controls secretory fat commitment through lateral inhibition in small intestine (PubMed:21238454, PubMed:21915337). Plays a role during inner ear development; negatively regulates auditory hair cell differentiation (PubMed:16495313). Plays a role during nephron development through Notch signaling pathway (PubMed:23806616). Regulates growth, blood pressure and energy homeostasis (PubMed:19562077).
Delta-like protein 1, Drosophila Delta homolog 1, Delta1, Dll1
Mouse DLL1 ELISA Kit is a single-wash 90-min Simplestep used to quantify Mouse DLL1 with a sensitivity of 24 pg/ml. The assay uses a simple mix-wash-read protocol with just one incubation and one wash step.
- Colorimetric Sandwich ELISA - 450 nm readout : works on any standard plate reader
- Design your own immunoassay: we also offer the conjugation-ready antibody pair
Sample | n | mean | SD | C.V. |
---|---|---|---|---|
Sample Mouse Serum | n 5 | mean - | SD - | C.V. 2.8 |
Sample | n | mean | SD | C.V. |
---|---|---|---|---|
Sample Mouse Serum | n 3 | mean - | SD - | C.V. 7.2 |
Sample type | Average % | Range |
---|---|---|
Sample type Cell culture supernatant | Average % = 99 | Range 94 - 104 % |
Sample type Serum | Average % = 100 | Range 99 - 101 % |
Sample type Citrate plasma | Average % = 104 | Range 103 - 106 % |
Sample type EDTA Plasma | Average % = 103 | Range 102 - 105 % |
Sample type Heparin Plasma | Average % = 101 | Range 98 - 104 % |
Mouse DLL1 ELISA Kit (ab208342) is a single-wash 90 min sandwich ELISA designed for the quantitative measurement of DLL1 protein in cell culture supernatant, serum, and plasma. It uses our proprietary SimpleStep ELISA® technology. Quantitate Mouse DLL1 with 24 pg/ml sensitivity.
SimpleStep ELISA® technology employs capture antibodies conjugated to an affinity tag that is recognized by the monoclonal antibody used to coat our SimpleStep ELISA® plates. This approach to sandwich ELISA allows the formation of the antibody-analyte sandwich complex in a single step, significantly reducing assay time. See the SimpleStep ELISA® protocol summary in the image section for further details. Our SimpleStep ELISA® technology provides several benefits:
- Single-wash protocol reduces assay time to 90 minutes or less
- High sensitivity, specificity and reproducibility from superior antibodies
- Fully validated in biological samples
- 96-wells plate breakable into 12 x 8 wells strips
A 384-well SimpleStep ELISA® microplate (Pre-coated 384 well Microplate SimpleStep ELISA® ab203359) is available to use as an alternative to the 96-well microplate provided with SimpleStep ELISA® kits.
DLL1 (Delta-like protein 1) is a transmembrane glycoprotein that is needed during development for cell-to-cell communication in embryos and in the nervous system development. In adult tissues, DLL1 is involved in morphogenesis and remodeling and is overexpressed in several types of cancers.
The protein known as Delta-like 1 (DLL1) also referred to as DLL 1 or DLL1 protein is an essential component in various cellular mechanisms. DLL1 typically has a molecular mass of approximately 80 kDa. This protein is mainly expressed in tissues related to development such as the nervous system bone marrow and certain parts of the embryonic organs. DLL1 functions mechanic-wise as a ligand for the Notch receptor family playing a role in signal transduction and influencing cell fate decisions.
Delta-like 1 protein is involved in several cell differentiation processes impacting tissue development. The protein is a member of the Notch signaling pathway which is important for mediating communication between adjacent cells. It interacts with Notch receptors to regulate transcriptional activities and promote different cell lineages. DLL1 does not function in isolation; it works as a part of a larger protein complex that includes intracellular domains and other signal modifiers.
Delta-like 1 fits into the Notch signaling pathway and the Wnt pathway. In the Notch signaling pathway DLL1 engages with Notch receptors to drive transcriptional responses important for embryogenesis and cell fate choices. In the Wnt pathway DLL1 interacts to modulate cellular growth and differentiation often in conjunction with proteins such as Jagged1 and Notch1. These pathways are essential in maintaining stem cell niches and influencing neurogenesis.
Delta-like 1 protein bears significance in oncological and congenital disorders. Dysregulation of DLL1 is associated with cancers like T-cell acute lymphoblastic leukemia where altered Notch signaling plays a role in tumor progression. Additionally abnormalities in DLL1 expression relate to congenital heart defects indicating its role in cardiac development. DLL1's interaction with Notch receptors such as Notch3 appears significant in these contexts making it a potential target for therapeutic intervention in both cancer and congenital disorder management.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Example of mouse DLL1 standard.
Background-subtracted data values (mean +/- SD) are graphed.
Interpolated concentrations of native DLL1 in (mouse) serum and plasma samples.
The concentrations of DLL1 were measured in duplicates, interpolated from the DLL1 standard curves and corrected for sample dilution. Undiluted samples are as follows: serum 5%, plasma (citrate) 5%, plasma (heparin) 2.5% and spleen supernatant 25%. The interpolated dilution factor corrected values are plotted (mean +/- SD, n=2). The mean DLL1 concentration was determined to be 26 ng/mL in serum, 26 ng/mL in plasma (citrate), 34 ng/mL in plasma (heparin) and 29 ng/mL in plasma (EDTA).
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com